2026 International Congress Archives - Page 151 of 208

Postural Stability After CSF Drainage in Idiopathic Normal Pressure Hydrocephalus: Association with Gait Response

HJ. Chang, JH. Kim, EJ. Kwon, S. Jeong, E. Oh (Daejeon, Republic of Korea)
Postural Sway Frequencies in Isolated REM Sleep Behavior Disorder Might Indicate Subtle Motor Impairments as Prodromal Marker of Parkinson’s Disease

D. Engel, P. Carlson-Kuhta, M. Lim, H. Hameed, K. Ehgoetz Martens, F. Horak, M. Mancini, M. Sommerauer (Bonn, Germany)
Power Spectral Density Increases Covary with Clinical Overstimulation During Dystonia Deep Brain Stimulation Programming

P. Bisarad, M. Pascual, J. Kelbert, S. Chinander, R. Gelineau-Morel, C. Gorodetsky, A. Hewitt, T. Larsh, N. Lucente, J. O'Malley, L. van Derwerf, J. Hauptman, T. Sanger, F. Ponce, M. Kruer, J. Thompson (Phoenix, USA)
PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

N. Singh, V. Singh (bathinda, India)
PPP2R2B Splice Variant Dysregulation Promotes Mitochondrial Association and Neuronal Apoptosis in iPSC-Derived Neurons from Spinocerebellar Ataxia Type 12 Patient

S. Sengupta, R. Banerjee, J. Rungta, B. Reddy, S. Ansari, R. Khatun, R. Mukhopadhyay, S. Pal, J. Ganguly, D. Dutta, S. Mukherjee, P. Basu, S. Choudhury, R. Pal, S. Chattarji, H. Kumar (Kolkata, India)
PPP2R5D Variants in Patients Diagnosed With Parkinson’s Disease. A Large‑Scale Multi‑Cohort Analysis

I. Keller Sarmiento, R. Bovenzi, V. Quintana, G. Cogan, A. Brice, A. Gajos, M. Bozi, L. Lange, G. Benbir Senel, B. Tserensodnom, H. Kim, M. Marti, A. Dilliott, H. Morris, S. Lim, A. Tan, R. Alcalay, J. Trinh, C. Klein, N. Mencacci (Chicago, USA)
Prasinezumab in Early-Stage Parkinson’s Disease: Additional Data from the PADOVA Study

T. Nikolcheva, G. Pagano, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, N. Pross, A. Monnet, G. Kerchner, P. Brundin, A. Bonni (Basel, Switzerland)
Prasinezumab’s Impact on Neuromelanin- and Iron-Sensitive MRI Biomarkers in Parkinson’s disease: Findings From the PADOVA Phase IIb Study

T. Kustermann, š. Holiga, R. Akande, J. Anzures-Cabrera, N. Pross, A. Monnet, T. Nikolcheva, G. Pagano (Welwyn Garden City, United Kingdom)
Precision Gene Therapy Results in Clinical Benefit and Developmental Gains in Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): The UK Experience

A. Spagarino, A. Salazar-Villacorta, R. Spaull, A. Soo, J. Hassell, S. Pope, S. Heales, R. Shihurkar, L. Carr, K. Aquilina, M. Kurian (London, United Kingdom)
Predicting Dementia in Parkinson’s Disease Using Blood-Based Proteomics

R. Real, Y. Kordovska, O. Swann, A. Nodehi, Y. Ben-Shlomo, N. Williams, D. Grosset, J. Hardy, A. Heslegrave, H. Zetterberg, H. Morris (London, United Kingdom)